In this review, we report the useful characteristics of fructooligosaccharides (Neosugar) . (3) . Individual bacterial species were suspended in PYF broth and then used for the test. Test medium was prepared by adding each sugar to PYF broth in a concentration of 0.5%. To determine the utilization of sugars, 0.1 ml of inoculum (109 CFU/ml) was used per 5 ml of test medium. Incubation was carried out at 37°C for 48 hr anaerobically by the Gas-Pak method (BBL Microbiology Systems, Cockeysville, MD) . The utilization of each sugar was judged from bacterial growth and acid production by measurement of the optical density and pH of the medium, respectively. 4) Investigation of intestinal microflora: Fresh fecal specimens were collected, kept at 4°C and then anaerobically transported to the laboratory. After homogenization, specimens (1 g) were dissolved in 9 ml of anaerobic diluent (13) and mixed thoroughly, and then a series of 10-fold dilutions (10-1 to 10-8) was prepared. According to the method of Mitsuoka et al. (13) 2) Utilization of Neosugar by intestinal bacteria: Prior to investigation of the influence of Neosugar on the intestinal microflora in vivo, the utilization by individual intestinal bacterial species was examined in vitro. The results are shown in Table 3 . Neosugar was utilized as well as raffinose by bifidobacteria except for Bijidobacterium bifidum. Compared with other sugars, Neosugar was not utilized by Lactobacillus fermentum, Escherichia coli or Clostridium perfringens. In this experiment, species of the Bacteroides fragilis group such as B. fragilis, B. thetaiotaomicron, B. vulgatus, B. distasonis and B. ovatus utilized all the examined sugars.
3) Changes in intestinal microflora by intake of Neosugar: Prepared in the foods shown in Table 2 , Neosugar (8g per day) was administered daily for two weeks to 23 senile inpatients ranging from 50 to 90 years of age. Somewhat different from the results obtained in the in vitro experiment, only the number of bifidobacteria and total bacteria increased significantly from 4 to 7 days after administration of Neosugar (Table  4 ). The average number of bifidobacteria per gram of stool increased about 10 times from 108.8 (frequency of occurrence, 87%) to 109.7 (frequency of occurrence, 100%) after 14 days of administration of Neosugar. The total counts also increased from 1010.1 to 1010.3. These results suggest that bifidobacteria utilize Neosugar more rapidly than the species of the Bacteroides fragilis group, which are the dominant bacteria in the human intestine, or other species in vivo.
Although there was no significant difference, lactobacilli showed a tendency to increase from 107.0 to 107.8, and the occurrence of Clostridium perfringens showed a tendency to decrease from 43.5% to 31.6%.
In individual cases, in the subjects who had a relatively small number of bifidobacteria such as 107.9 and 105.5 per gram of stool, the counts increased to 1010, i.e., about 100 and 10,000 times the initial counts, respectively, and the ratio of bifidobacteria to the total counts reached nearly 70% after 14 days of administration ( Fig. 3-A,  B) . In the cases of the subjects who had a relatively large number of bifidobacteria, e.g., 109 and 1010 per gram of stool, their counts did not show marked changes (Fig.  4-A, B) , but during the administration of Neosugar, Clostridium perfringens was not detectable. Figure 5 shows the correlation between the average count of bifidobacteria and the occurrence of Clostridium perfringens on each examination day. As a result, a significant negative correlation was recognized between them. This result suggests that a large number of bifidobacteria may suppress the growth of Clostridium perfringens in the human intestine by producing acetic and lactic acids.
In this experiment, 6 subjects had loose stool before the test, but by taking Neosugar the stool condition was gradually improved and became normal after 8 days of administration in all the subjects.
On the other hand, we tried to administer Neosugar to patients with serious or moderate constipation. As a result, Neosugar was effective in patients with moderate constipation (11, 21) , and the number of bifidobacteria also increased in those effective cases.
These facts suggest that the intake of Neosugar normalizes the stool conditions of diarrhea or moderate constipation by improving the balance of the intestinal microflora.
4) Dose-response test of Neosugar for increasing intestinal bifidobacteria : We have already observed that intestinal bifidobacteria were selectively increased by taking 8g of Neosugar per day. To determine the minimum dose giving this effect, we administered 1, 2 and 4g per day of Neosugar to 21 senile persons ranging from 54 to 88 years of age. Figure 6 shows the effect of the amount of Neosugar on increasing the intestinal bifidobacteria counts in individual subjects. Intake of even 1 g of Neosugar per day increased the bifidobacteria, although the rate of increase was slower as the dose was reduced.
5) Effect of Neosugar on the production of putrefactive substances in rats: Mitsuoka reported that some intestinal microorganisms may form substances noxious to the host (15) . Intake of Neosugar improves the balance of the intestinal microflora as described above. So we investigated the effect of Neosugar on the suppression of putrefaction in the intestine by feeding rats on the diet containing tyrosine and tryptophan.
The changes in the fecal volatile fatty acids (VFAs) are shown in Fig. 7 . No significant differences in fecal VFAs were observed between the control diet group, show the concentration of the VFAs in the three periods: the upper, the initial basal diet period; the middle, the experimental diet period; the lower, the final basal diet period. C2, Acetic acid; C3, propionic acid; C4, n and iso-butyric acid; C5, n and iso-valeric acid O, pH. the 0.4% Neosugar diet group and the 2% Neosugar diet group. But the administration of the 10% Neosugar diet caused a remarkable increase in the fecal VFAs and a decrease in the fecal pH.
The changes in the fecal and urinary putrefactive products are shown in Figs. 8 and 9. Phenol and p-cresol are putrefactive products produced from tyrosine. Indole is also a putrefactive product produced Fig. 9 . Effect of Neosugar on the formation of putrefactive products in urine. Three columns in each group mean the urinary putrefactive products in the three periods as described in the legend to Fig. 7 . from tryptophan. Putrefactive products absorbed from the gut are conjugated with sulfuric or glucuronic acid in the liver and excreted in the urine.
Fecal and urinary phenolic compounds increased in accordance with aging or the addition of tyrosine. However, the administration of Neosugar showed a suppressive effect on the fecal and urinary phenolic compounds. Especially the administration of the 10% Neosugar diet resulted in a drastic decrease in the phenolic compounds. This effect was continued even in the final basal diet period, when Neosugar was no longer being administered.
On the other hand, the amount of indole in the feces was very small in comparison with the fecal phenolic compounds, and no significant differences in the urinary indican (the potassium salt of indoxyl sulfate) were observed between each group or each period.
6) Application of Neosugar to human subjects: To confirm the beneficial effects of Neosugar on the intestinal condition of humans, 8 g of Neosugar was administered to healthy adults every day for 2 months. Figures 10 and 11 show the changes in the intestinal microflora, VFAs and putrefactive products in 2 persons. In the case of Fig. 10 , whose microflora had been relatively poor in bifidobacteria before the administration, the number of bifidobacteria increased from 107.0 to 1010.0 per gram of stool, and their ratio to the total counts also increased from 0.9% to 71.3% by administration of Neosugar ( Fig. 10-A) . The amount of VFAs in this subject increased ( Fig. 10-B) , while the putrefactive products decreased (Fig. 10-C) , reflecting the changes in the microflora. In the case of Fig. 11 , whose microflora had been rich in bifidobacteria and the amount of putrefactive products in the stool had been quite low at the beginning of Neosugar administration, the number of bifidobacteria was not changed (Fig. 11-A) . However, the ratio of bifidobacteria was increased, and the low level of putrefactive products was also maintained (Fig. 11-C ). Veillonellae were detectable after the administration of Neosugar in both cases. This is interesting, because veillonellae ferment lactic acid, which is produced by bifidobacteria. So the increase of veillonellae may be due to the increase in bifidobacteria. The fecal pH, solid percent and amount of putrefactive products of the latter subject were lower than those of the former subject. These results indicate that when the number and/or ratio of bifidobacteria is high, putrefaction in the gut is effectively suppressed. And Neosugar effectively suppresses putrefaction in the intestine through the increase in the number of bifidobacteria , especially in persons whose intestinal microflora is initially poor in bifidobacteria . confirmed in other hospitals (4, 5, 24) . Fructooligosaccharides are also useful for domestic animals and pets, as shown in Table 5 . The intake of fructooligosaccharides also suppressed the formation of putrefactive products in the digestive tract, in animals as well as humans. The putrefactive products come from amino acids, which should be utilized as nutrients for animals. Therefore, the suppression of putrefaction will also improve nutrition and 
